norethindrone and tak 385

norethindrone has been researched along with tak 385 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Syed, YY1
Arjona Ferreira, JC; Johnson, B; Lee, TY; Li, Y; Lukes, A; Migoya, E1

Reviews

1 review(s) available for norethindrone and tak 385

ArticleYear
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
    Drugs, 2022, Volume: 82, Issue:15

    Topics: Acetates; Estradiol; Female; Humans; Leiomyoma; Menorrhagia; Norethindrone; Norethindrone Acetate; Uterine Neoplasms

2022

Trials

1 trial(s) available for norethindrone and tak 385

ArticleYear
A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.
    Clinical pharmacokinetics, 2023, Volume: 62, Issue:8

    Topics: Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Phenylurea Compounds

2023

Other Studies

1 other study(ies) available for norethindrone and tak 385

ArticleYear
Relugolix, Estradiol, and Norethindrone Acetate.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2021, Sep-22, Volume: 78, Issue:19

    Topics: Estradiol; Humans; Norethindrone; Norethindrone Acetate; Phenylurea Compounds; Pyrimidinones

2021